CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 15 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $688,000 | -0.7% | 1,035,000 | 0.0% | 0.00% | – |
| Q2 2022 | $693,000 | -5.7% | 1,035,000 | 0.0% | 0.00% | – |
| Q1 2022 | $735,000 | +12.7% | 1,035,000 | 0.0% | 0.00% | – |
| Q4 2021 | $652,000 | -10.9% | 1,035,000 | +2.0% | 0.00% | – |
| Q3 2021 | $732,000 | -1.6% | 1,015,000 | 0.0% | 0.00% | – |
| Q2 2021 | $744,000 | -1.6% | 1,015,000 | +1.5% | 0.00% | – |
| Q1 2021 | $756,000 | -44.8% | 1,000,000 | -50.0% | 0.00% | – |
| Q4 2020 | $1,370,000 | +10.5% | 2,000,000 | 0.0% | 0.00% | – |
| Q3 2020 | $1,240,000 | +6.9% | 2,000,000 | 0.0% | 0.00% | – |
| Q2 2020 | $1,160,000 | -6.5% | 2,000,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,240,000 | -24.1% | 2,000,000 | -33.3% | 0.00% | – |
| Q4 2019 | $1,634,000 | -20.1% | 3,000,000 | -33.3% | 0.00% | -100.0% |
| Q3 2019 | $2,046,000 | -7.6% | 4,500,000 | +28.6% | 0.00% | 0.0% |
| Q2 2019 | $2,215,000 | -4.5% | 3,500,000 | +16.7% | 0.00% | 0.0% |
| Q1 2019 | $2,319,000 | -5.3% | 3,000,000 | -14.3% | 0.00% | 0.0% |
| Q4 2018 | $2,450,000 | -58.3% | 3,500,000 | -53.3% | 0.00% | 0.0% |
| Q3 2018 | $5,877,000 | +16.0% | 7,500,000 | +36.4% | 0.00% | 0.0% |
| Q2 2018 | $5,065,000 | – | 5,500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|